Seres Therapeutics, Inc. (MCRB) vs NanoViricides, Inc. (NNVC)
Seres Therapeutics, Inc. and NanoViricides, Inc. are both Biotechnology companies. Seres Therapeutics, Inc. and NanoViricides, Inc. are of similar size ($38.0M and $36.0M). NanoViricides, Inc. has the higher net margin (0.00% vs −1,192.9%) and the higher return on invested capital (−86.0% vs −277.3%). Across the 13 metrics below, NanoViricides, Inc. leads on 9 and Seres Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | MCRB | NNVC | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (4,462.77%) | 0.00% | 0.00% |
| Net margin | (1,192.94%) | 0.00% | 0.00% |
| Free cash flow margin | (2,721.83%) | 0.00% | 0.00% |
| Return on equity | (66.57%) | (89.97%) | (57.72%) |
| Return on assets | (18.31%) | (79.91%) | (49.22%) |
| Return on invested capital | (277.30%) | (86.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack